Spinal hemangioblastoma: surgical procedures, outcomes and review of the literature.

Acta neurologica Belgica 2021 Vol.121(4) p. 973-981

Wang H, Zhang L, Wang H, Nan Y, Ma Q

Abstract

[PURPOSE] total removal of spinal hemangioblastomas with satisfactory clinical outcomes remains a challenge. We aimed to evaluate the surgical outcomes of our spinal hemangioblastomas patients, summarize our experiences with this condition and review-related literature.

[METHODS] records of 18 spinal hemangioblastoma patients who underwent microsurgical resection were analyzed retrospectively. Clinical features, surgical procedures and outcomes were reviewed to assess the prognosis of their spinal hemangioblastomas. The McCormick classification method was used to evaluate spinal function and MR scans used to assess location and features of the tumor pre-surgically, tumor recurrence and syringomyelia status post-surgically.

[RESULTS] total resection of 37 tumors was achieved in all 18 cases. Of those patients, two (11%) were accompanied with von Hippel-Lindau (VHL). Of the 37 tumors, 3 (8.1%) were completely intramedullary, 16 (43.2%) intramedullary-extramedullary and 18 (48.6%) primarily extramedullary. Tumors accompanied with syringomyelia were present in 17 (94.4%) patients. Clinical symptoms such as pain were reduced within 48 h after surgery in 16 patients. Post-operative neurological functions improved in all cases at 3 months post-surgery. Over the subsequent 3-18 month follow-up period, pre-operative symptoms improved in all 18 patients and no tumor recurrence was present. Syringomyelia was reduced or absent within 3-6 months.

[CONCLUSIONS] our results indicated that a complete microscopic resection was effective in eliminating symptoms in these spinal hemangioblastoma patients, who showed a good prognosis after surgery. These improvements in clinical symptoms may be associated with the blood flow changes, but not with reductions and/or eliminations of syrinx after surgery.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 spinal scispacy 1
해부 intramedullary scispacy 1
해부 blood scispacy 1
약물 [PURPOSE] total scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Spinal hemangioblastoma C4024223
Spinal hemangioblastoma
scispacy 1
질환 hemangioblastomas C0206734
Hemangioblastoma
scispacy 1
질환 hemangioblastoma C0206734
Hemangioblastoma
scispacy 1
질환 tumor C0027651
Neoplasms
scispacy 1
질환 syringomyelia C0039144
Syringomyelia
scispacy 1
질환 tumors C0027651
Neoplasms
scispacy 1
질환 von Hippel-Lindau C0019562
Von Hippel-Lindau Syndrome
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 Syringomyelia was reduced or absent within 3-6 scispacy 1
질환 spinal hemangioblastomas scispacy 1
질환 spinal hemangioblastomas patients scispacy 1
질환 spinal hemangioblastoma patients scispacy 1
질환 von Hippel-Lindau (VHL scispacy 1
질환 syrinx scispacy 1
기타 patients scispacy 1

MeSH Terms

Adolescent; Adult; Aged; Female; Follow-Up Studies; Hemangioblastoma; Humans; Male; Middle Aged; Retrospective Studies; Spinal Cord Neoplasms; Thoracic Vertebrae; Treatment Outcome; Young Adult